Search for: "Merck Pharmaceuticals"
Results 21 - 40
of 1,035
Sort by Relevance
|
Sort by Date
4 Sep 2023, 1:05 am
(May 2021)New SPC referral to the CJEU on the interpretation of Art 3(a) and (c) for combination products (Merck v Clonmel) (March 2022) [read post]
24 Aug 2023, 9:41 am
NovartisNovartis owned a European patent (EP 0 948 320) relating to pharmaceutical compositions for sustained release of the HMG-CoA reductase inhibitor Fluvastatin. [read post]
25 Jul 2023, 1:43 am
Merck Sharp & Dohme Corp). [read post]
9 Jul 2023, 9:05 pm
Last month, the pharmaceutical company Merck filed a lawsuit that alleges that the Medicare price negotiation program created by the Inflation Reduction Act will lead to an unconstitutional taking of its patented medicines. [read post]
26 Jun 2023, 1:38 am
Chamber of Commerce (complaint here), in New Jersey by Bristol Myers Squibb (complaint here), and in Texas by Pharmaceutical Research and Manufacturers of America (PhRMA) and others (complaint here). [read post]
8 Jun 2023, 7:43 am
Examples of the latter include the Bristol-Myers-Squibb – Celgene merger in 2018, and the Merck-Wyeth merger of 2009. [read post]
8 Jun 2023, 7:43 am
Examples of the latter include the Bristol-Myers-Squibb – Celgene merger in 2018, and the Merck-Wyeth merger of 2009. [read post]
7 Jun 2023, 2:21 am
First, Merck characterizes the program as a “per se taking” without just compensation under the Fifth Amendment, because manufacturers are “force[d] . . . to transfer their patented pharmaceutical products to Medicare beneficiaries, for public use” at a government-dictated price that is a fraction of the drug’s value. [read post]
6 Jun 2023, 11:25 am
Here, the pharmaceutical products are "private property" under Horne v. [read post]
4 May 2023, 2:31 pm
Hostile or Warlike Exclusions On May 1, 2023, the New Jersey Superior Court Appellate Division issued a ruling in the case of pharmaceutical giant, Merck, which was hit by NonPetya attack, which the U.S. government attributed to the Russian government. [read post]
27 Apr 2023, 5:50 am
As Bloomberg reported today, Germany has also proposed export controls on the sale of chemicals for semiconductor production to China; the German chemical company Merck has a hand in the production of nearly every chip as a key supplier of chemicals like photoresists that are used to print patterns onto semiconductors. [read post]
6 Apr 2023, 6:38 am
The judge reviewed the national case law on selections/deletions from multiple lists (Merck v Shionogi [2016] EWHC 2989 (Pat), Nokia v IPCom [2012] EWCA Civ 567 and GlaxoSmithKline v Wyeth [2016] EWHC 1045 (Pat)) and the EPO cases reviewed therein and in the EPO Case Law Book. [read post]
28 Mar 2023, 4:46 am
In November 2020, the BRPTO rejected without further administrative appeal a patent application filed by Merck Sharp & Dohme (MSD) on January 8, 2009, after the applicant failed to respond to an office action and later to appeal the decision rejecting the application. [read post]
24 Mar 2023, 6:28 am
It is common practice in the pharmaceuticals sector for medicinal products to bear several different marks on their packaging, namely the product mark and the manufacturer's. [read post]
7 Mar 2023, 1:42 pm
But Merck & Co., a New Jersey-based pharmaceutical company, was under attack. [read post]
13 Feb 2023, 2:40 pm
EU/1/15/1024 for pembrolizumab, granted to Merck Sharp & Dohme. [read post]
11 Feb 2023, 7:17 pm
Strafford will be offering a webinar entitled "Orange Book Listing Recent Developments -- Impact on Prosecution of Pharmaceutical U.S. [read post]
16 Nov 2022, 6:09 am
To wit, case 910/9215/21 interpreted the Law No 2174-IX to mean that patent rights, which expire while martial law is in force, shall be extended until the end of the war.In that case, the US pharmaceutical company Merck & Co. filed a lawsuit in 2021 against Teva Ukraine (a subsidiary of Israeli pharmaceutical company Teva), Merck & Co. requesting that Teva Ukraine cease infringement of Merck’s rights to a patent No 55409… [read post]
25 Oct 2022, 8:30 am
Spanish anitrust agency Comisión Nacional de los Mercados y la Compentencia (CNMC) Tuesday fined US pharmaceutical company Merck Sharp and Dohme (MSD) 39 million euros for abuse of the market. [read post]
17 Oct 2022, 12:28 am
Notifications were filed with respect to SPCs relating to sugammadex, sitagliptin, sitagliptin/metformin, vildagliptin, vildagliptin/metformin, rivaroxaban and ticagrelor and the manufacturers involved were Galenicum, Farmhispania, Biogaran, Normon Labs, Liconsa Labs, Kern Pharma, Cinfa Labs, Pensa Pharma, Alter Labs and Merck. [read post]
